A humanised mouse model reveals pathways to enhance longevity

A humanised mouse model now produces mature, class-switched, and hypermutated antibodies, offering insights into immune responses and advancing vaccine and antibody therapy research. This model may accelerate immunity understanding, supporting healthspan and longevity research.

Slowing brain ageing through region-specific Alzheimer’s insights

Single-cell analysis maps Alzheimer’s progression across brain regions, revealing specific cellular and molecular changes. The findings suggest targeted interventions could address Alzheimer’s-related dysfunction, potentially slowing progression and preserving brain health.

Reversing age-related brain decline with OSKM gene therapy

OSKM gene therapy in the hippocampus rejuvenates cognitive function in aged rats, improving spatial memory and cognitive abilities without harmful effects. The treatment reverses age-related DNA methylation changes, suggesting potential for brain rejuvenation and delaying cognitive decline.

SIRT6’s role in slowing ageing and preventing diseases

SIRT6 regulates DNA repair and metabolic pathways, extending lifespan in mice by stabilising chromatin structure and preventing age-related diseases. This highlights potential therapeutic strategies for improving healthspan and longevity.

Tracking DNA methylation: A new biomarker for ageing

The PRC2-AgeIndex is a biomarker that tracks age-related changes in DNA methylation at specific sites linked to the Polycomb Repressive Complex 2 (PRC2). It effectively measures methylation gains in somatic cells and may help assess the impact of anti-aging treatments across different tissues

Blocking IL-11 to extend lifespan and reduce frailty in ageing

Blocking IL-11, a pro-inflammatory protein, extended lifespan and improved health in mice, reducing frailty and metabolic decline. Inhibiting IL-11 led to a lifespan increase of up to 25%, showing promise as a therapeutic target for enhancing human healthspan.​